Centocor deal

Centocor Inc. (CNTO) CNTO and Tanabe Seiyaku Co. Ltd. (Japan) agreed to develop CenTNF, CNTO's chimeric monoclonal antibody-based drug, to treat rheumatoid arthritis and inflammatory bowel diseases ...